Rentomed Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -66.61%
- Profit Growth -274.01%
- Ebitda -295.60%
- Net Worth -288.61%
- Total Assets -36.24%
About Rentomed
Rentomed Private Limited (RPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 16 July 2020 (Four years and seven months 10 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Sonvane and Shriram Sonawane serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33309PN2020PTC192056
- Company No.
192056
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Rentomed?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shriram Sonawane  | Managing Director | 16-Jul-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geeta Sonvane | Director | 16-Jul-2020 | Current |
Financial Performance of Rentomed.
Rentomed Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 66.61% decrease. The company also saw a substantial fall in profitability, with a 274.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 288.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rentomed?
Unlock access to Rentomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kite Medica Private LimitedShriram Sonawane is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rentomed?
Rentomed has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rentomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rentomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.